Loading...
Symbols:
Loading...
Symbols:
BioMarin Pharmaceutical Inc. (BMRN)
|
|
|
| 52wk high: | |
| 52wk low: | |
| EPS: | |
| PE: | |
| Dividend: | |
| Yield: | |
| Market Cap: | |
| Exchange: |
Articles on BioMarin Pharmaceutical Inc. (BMRN)
37 articles
Filter by:
Latest Articles Most commented on articlesMost frequent authors on BMRN
- SA Editor Miriam Metzinger(13)
- SA Editors(9)
- Robert Zenilman(5)
- Mike Havrilla(4)
- Zacks.com (4)
Most popular authors
(tracked in watchlists)
- SA Editor Eli Hoffmann(387)
- Andrew Wilkinson(334)
- Zacks.com (127)
- SA Editor Miriam Metzinger(120)
- Notable Calls(112)
Most commented on authors
- SA Editor Eli Hoffmann(28)
- SA Editor Miriam Metzinger(17)
- Mike Havrilla(9)
- BioBlogger (5)
- Zacks.com (3)
- New Emerging Biotech and Pharma Company Index
- Four Biotechs at Attractive Entry Points
- Even Fatter Yields for Pfizer; M&A Targets in the Sector
- Friday Options Update: MS, XLF, GFG, MTB, XLB, BMRN, IWM
- Biotech Outlook: M&A Will Continue
- Biotech Buying Binge About to Begin?
- Big Biotech Booms But IBB Falls Flat
- BioMarin, Myriad, and Regeneron Show a Quiet Strength
- Biotech Sector Continues to Outperform
- Five Biotech Stocks to Weather a Down Market
- Smallcap BioMarin's Drug Kuvan Showing Great Promise
- Gold's Just Getting Started - Barron's Interview
- Biotech Fund IBB May Ride the M&A Frenzy, but It's Still Wildly Volatile
- Look Who's Buying Shares of BioMarin Pharmaceutical
- Biotech Day in Review: Shire Buys New River for $2.6 Billion
- Biotech Stocks Day-in-Review: BioCryst Begins Pivotal Trial of Fodosine
- Biotech Stocks Day-in-Review: Controversy For Genentech Cancer Drug
- BioMarin Recieves Approval for Aldurazyme in Japan
- Chart: Biotech Stocks - Annual Earnings Growth
- Chart: Biotech Stocks - Quarterly Earnings Growth
-
Analyst Upgrades & Downgrades for Wednesday, July 19, 2006
on Jul 19, 2006
- Chart: Biotech Stocks - Annual Revenue Growth (Last 12 Months Reported)
- Chart: Biotech Stocks - Quarterly Revenue Growth
- Chart: Biotech Stocks - Change in Cash-On-Hand
-
Chart: Biotech Stocks - Normalized Net Income Per Employee
on Jun 09, 2006
- Chart: Biotech Stocks - Revenue Per Employee
- Chart: Biotech Stocks - Normalized Net Profit Margins
- Chart: Biotech Stocks - SG&A Margin (MRQ)
- Chart: Biotech Stocks - Gross Profit Margins
- Chart: Biotechnology Companies - Annual Net Income Growth
- Chart: Biotech Stocks - Annual Revenue Growth
- Short Interest Ratio for Biotech Companies
- Price/Sales (Trailing 12 Months) for Biotech Companies
- Earnings Schedule and Estimates for Thursday, Feb. 23
- Biotech Stocks Q4 2005 Earnings Scorecard
-
Biotech Stocks Q3 2005 Earnings Scorecard
on Nov 04, 2005
-
Stocks Covered by The Biotech Stock Blog
on Oct 11, 2005
Hedge Fund Jobs
Job Seekers: Search jobs by category, get job alerts by email or live feed, apply online See full list of jobs »
Employers: See all recruitment options, get applications online or by email Post a job »